190 related articles for article (PubMed ID: 21285292)
1. AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure.
Beauloye C; Bertrand L; Horman S; Hue L
Cardiovasc Res; 2011 May; 90(2):224-33. PubMed ID: 21285292
[TBL] [Abstract][Full Text] [Related]
2. Analysis of metabolic remodeling in compensated left ventricular hypertrophy and heart failure.
Kato T; Niizuma S; Inuzuka Y; Kawashima T; Okuda J; Tamaki Y; Iwanaga Y; Narazaki M; Matsuda T; Soga T; Kita T; Kimura T; Shioi T
Circ Heart Fail; 2010 May; 3(3):420-30. PubMed ID: 20176713
[TBL] [Abstract][Full Text] [Related]
3. Metformin improves cardiac function in rats via activation of AMP-activated protein kinase.
Wang XF; Zhang JY; Li L; Zhao XY; Tao HL; Zhang L
Clin Exp Pharmacol Physiol; 2011 Feb; 38(2):94-101. PubMed ID: 21143620
[TBL] [Abstract][Full Text] [Related]
4. AMPK activators--potential therapeutics for metabolic and other diseases.
Zhou G; Sebhat IK; Zhang BB
Acta Physiol (Oxf); 2009 May; 196(1):175-90. PubMed ID: 19245659
[TBL] [Abstract][Full Text] [Related]
5. AMP-activated protein kinase in the control of cardiac metabolism and remodeling.
Horman S; Beauloye C; Vanoverschelde JL; Bertrand L
Curr Heart Fail Rep; 2012 Sep; 9(3):164-73. PubMed ID: 22767403
[TBL] [Abstract][Full Text] [Related]
6. Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload.
Doenst T; Pytel G; Schrepper A; Amorim P; Färber G; Shingu Y; Mohr FW; Schwarzer M
Cardiovasc Res; 2010 Jun; 86(3):461-70. PubMed ID: 20035032
[TBL] [Abstract][Full Text] [Related]
7. Cardiac metabolism in hypertrophy and heart failure: implications for therapy.
Siddiqi N; Singh S; Beadle R; Dawson D; Frenneaux M
Heart Fail Rev; 2013 Sep; 18(5):595-606. PubMed ID: 23124940
[TBL] [Abstract][Full Text] [Related]
8. Energy homeostasis and cancer prevention: the AMP-activated protein kinase.
Fay JR; Steele V; Crowell JA
Cancer Prev Res (Phila); 2009 Apr; 2(4):301-9. PubMed ID: 19336731
[TBL] [Abstract][Full Text] [Related]
9. Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats.
Zhang CX; Pan SN; Meng RS; Peng CQ; Xiong ZJ; Chen BL; Chen GQ; Yao FJ; Chen YL; Ma YD; Dong YG
Clin Exp Pharmacol Physiol; 2011 Jan; 38(1):55-62. PubMed ID: 21083698
[TBL] [Abstract][Full Text] [Related]
10. The role of phospho-adenosine monophosphate-activated protein kinase and vascular endothelial growth factor in a model of chronic heart failure.
Heidrich F; Sossalla S; Schotola H; Vorkamp T; Ortmann P; Popov AF; Coskun KO; Rajab TK; Friedrich M; Sohns C; Hinz J; Bauer M; Quintel M; Schöndube FA; Schmitto JD
Artif Organs; 2010 Nov; 34(11):969-79. PubMed ID: 21092039
[TBL] [Abstract][Full Text] [Related]
11. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S; Long CL; Wang RH; Wang H
Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
[TBL] [Abstract][Full Text] [Related]
12. Energy metabolism in heart failure.
Ventura-Clapier R; Garnier A; Veksler V
J Physiol; 2004 Feb; 555(Pt 1):1-13. PubMed ID: 14660709
[TBL] [Abstract][Full Text] [Related]
13. AMP-activated protein kinase (AMPK) molecular crossroad for metabolic control and survival of neurons.
Spasić MR; Callaerts P; Norga KK
Neuroscientist; 2009 Aug; 15(4):309-16. PubMed ID: 19359670
[TBL] [Abstract][Full Text] [Related]
14. Is AMPK the savior of the failing heart?
Kim TT; Dyck JR
Trends Endocrinol Metab; 2015 Jan; 26(1):40-8. PubMed ID: 25439672
[TBL] [Abstract][Full Text] [Related]
15. AMP-activated protein kinase control of energy metabolism in the ischemic heart.
Lopaschuk GD
Int J Obes (Lond); 2008 Sep; 32 Suppl 4():S29-35. PubMed ID: 18719595
[TBL] [Abstract][Full Text] [Related]
16. AMP-activated protein kinase in the heart: role during health and disease.
Arad M; Seidman CE; Seidman JG
Circ Res; 2007 Mar; 100(4):474-88. PubMed ID: 17332438
[TBL] [Abstract][Full Text] [Related]
17. The regulation of AMP-activated protein kinase by upstream kinases.
Carling D; Sanders MJ; Woods A
Int J Obes (Lond); 2008 Sep; 32 Suppl 4():S55-9. PubMed ID: 18719600
[TBL] [Abstract][Full Text] [Related]
18. AMP-activated protein kinase: a core signalling pathway in the heart.
Kim AS; Miller EJ; Young LH
Acta Physiol (Oxf); 2009 May; 196(1):37-53. PubMed ID: 19239414
[TBL] [Abstract][Full Text] [Related]
19. Heart spotting.
el Azzouzi H; De Windt LJ
Basic Res Cardiol; 2008 May; 103(3):228-31. PubMed ID: 18274799
[TBL] [Abstract][Full Text] [Related]
20. Role of oxidative stress in transition of hypertrophy to heart failure.
Dhalla AK; Hill MF; Singal PK
J Am Coll Cardiol; 1996 Aug; 28(2):506-14. PubMed ID: 8800132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
